Related Experiment Video
Updated: May 26, 2026
Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
Xiao-Jie-An Capsule Attenuates Oestrogen- and Progestogen-Induced Mammary Gland Hyperplasia by Modulating Sex Hormone
Kecheng Tang1, Yi Ying1, Feng Lu1
1Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing, China.
Abstract:
Xiao-Jie-An capsule (XJA), a traditional Chinese medicine formulation consisting of six herbal components, has been used to treat MGH for a long time. Aim of this study was to determine the therapeutical impact of XJA on an MGH rat model and the underlying mechanism. The MGH model was established by daily intramuscular injections of estradiol benzoate (0.5 mg/kg) for 25 days, then progesterone (5 mg/kg) for 5 days. Network pharmacological analysis and molecular biological assays were conducted to determine the pharmacological targets of XJA. XJA significantly reduced nipple height and diameter and effectively suppressed histopathological hallmarks of MGH. Additionally, XJA markedly decreased the expression of Ki67 and the expression of proliferating cell nuclear antigen, increased the terminal deoxynucleotidyl transferase dUTP nick-end labelling and lowered the Bcl-2/Bax ratio in mammary tissue of MGH rats. Furthermore, XJA modulated endocrine disorder by reducing blood follicle-stimulating hormone and estradiol (E2), while increasing luteinising hormone and androgen concentrations. Concomitant anti-inflammatory effects were found by decreased pro-inflammatory cytokines IL-1β, IL-2, IL-6 and TNF-α; inhibited TLR4 expression and attenuated NF-κB phosphorylation. Our experimental results suggest that XJA effectively mitigated oestrogen- and progesterone-induced MGH by modulating sex hormone levels and reducing inflammatory response.
Related Concept Videos
01:22Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
01:30Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
01:19Regulation of Hormone Secretion
Humoral stimuli,...
01:22Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
02:07Oogenesis